Botulinum Toxin—What Urologic Uses Does the Data Support?

Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury

(2013) C Jia et al.   SPINAL CORD

Long-term Efficacy and Safety of OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity: An Interim Analysis

(2013) Michael Kennelly et al.   UROLOGY

Botox® for idiopathic overactive bladder: efficacy, duration and safety. Effectiveness of subsequent injection

(2012) Roberta Granese et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)

(2012) Amar Mohee et al.   BJU INTERNATIONAL

Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study

(2012) Emilio Sacco et al.   BJU INTERNATIONAL

OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial

(2012) Clare J. Fowler et al.   EUROPEAN UROLOGY

Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)

(2012) Douglas G. Tincello et al.   EUROPEAN UROLOGY

EAU Guidelines on Surgical Treatment of Urinary Incontinence

(2012) Malcolm G. Lucas et al.   EUROPEAN UROLOGY

A Randomized Double-blind Placebo-controlled Phase 2 Dose-ranging Study of OnabotulinumtoxinA in Men with Benign Prostatic Hyperplasia

(2012) Michael Marberger et al.   EUROPEAN UROLOGY

Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients

(2012) Katsuya Hikita et al.   INTERNATIONAL JOURNAL OF UROLOGY

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

(2012) David Ginsberg et al.   JOURNAL OF UROLOGY

Persistent Therapeutic Effect of Repeated Injections of Onabotulinum Toxin A in Refractory Bladder Pain Syndrome/Interstitial Cystitis

(2012) Rui Pinto et al.   JOURNAL OF UROLOGY

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

(2012) David Sussman et al.   NEUROUROLOGY AND URODYNAMICS

Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence

(2012) Anthony G. Visco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: a pilot study

(2012) J Krhut et al.   SPINAL CORD

Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses

(2012) René Arnouk et al.   TheScientificWorldJOURNAL

Urodynamic Effects of Transrectal Intraprostatic Ona botulinum Toxin A Injections for Symptomatic Benign Prostatic Hyperplasia

(2012) Laetitia M.O. de Kort et al.   UROLOGY

Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates

(2012) Ali Hamidi Madani et al.   WORLD JOURNAL OF UROLOGY

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

(2011) Francisco Cruz et al.   EUROPEAN UROLOGY

Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates

(2011) Christopher Dowson et al.   EUROPEAN UROLOGY

Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity

(2011) Rustom P. Manecksha et al.   EUROPEAN UROLOGY

Contemporary Management of the Painful Bladder: A Systematic Review

(2011) Antonella Giannantoni et al.   EUROPEAN UROLOGY

Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis

(2011) Shahid Khan et al.   JOURNAL OF UROLOGY

Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial

(2011) E. David Crawford et al.   JOURNAL OF UROLOGY

Botulinum Toxin Type A in Patients With Parkinson's Disease and Refractory Overactive Bladder

(2011) Antonella Giannantoni et al.   JOURNAL OF UROLOGY

Efficacy of Botulinum Toxin A Injection for Neurogenic Detrusor Overactivity and Urinary Incontinence: A Randomized, Double-Blind Trial

(2011) Sender Herschorn et al.   JOURNAL OF UROLOGY

Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder

(2011) Eric Rovner et al.   NEUROUROLOGY AND URODYNAMICS

Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries

(2011) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Cost-Effectiveness of Sacral Neuromodulation Compared to Botulinum Neurotoxin A or Continued Medical Management in Refractory Overactive Bladder

(2011) Salvador Arlandis et al.   VALUE IN HEALTH

Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment

(2011) S. H. Alloussi et al.   WORLD JOURNAL OF UROLOGY

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients

(2011) S. Deffontaines-Rufin et al.   International Braz J Urol

Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity

(2010) Xavier Gamé et al.   BJU INTERNATIONAL

Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function

(2010) João Silva et al.   BJU INTERNATIONAL

Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder

(2010) Randall K. Leong et al.   BJU INTERNATIONAL

A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome

(2010) Henry P. Gottsch et al.   NEUROUROLOGY AND URODYNAMICS

Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity

(2010) Priya Padmanabhan et al.   WORLD JOURNAL OF UROLOGY

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

(2009) P. Abrams et al.   NEUROUROLOGY AND URODYNAMICS

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

(2007) Joop P. van de Merwe et al.   EUROPEAN UROLOGY